Chongqing Lummy Pharmaceutical Cash Flow-to-Debt Ratio
Chongqing Lummy Pharmaceutical cash flow-to-debt ratio. Chongqing Lummy Pharmaceutical (300006) has a Cash Flow-to-Debt Ratio of -0.02x as of September 2025, meaning its operating cash flow of CN¥-14.90 Million could theoretically repay 0% of its total liabilities (CN¥910.32 Million) in one year. Check Chongqing Lummy Pharmaceutical cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Chongqing Lummy Pharmaceutical (2006–2024)
Cash flow-to-debt ratio of Chongqing Lummy Pharmaceutical from 2006 to 2024. Historical debt coverage capacity for Chongqing Lummy Pharmaceutical across 19 annual periods. Check total reinvestment intensity of Chongqing Lummy Pharmaceutical to assess the company's total reinvestment commitment from operating cash flow.
Chongqing Lummy Pharmaceutical Cash Flow-to-Debt Ratio by Year (2006–2024)
Chongqing Lummy Pharmaceutical cash flow-to-debt ratio by year from 2006 to 2024. Year-by-year debt coverage analysis for Chongqing Lummy Pharmaceutical. For the full cash flow conversion analysis, see Chongqing Lummy Pharmaceutical cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.19x | CN¥185.03 Million | CN¥972.47 Million | ▲ +79.4% |
| 2023 | 0.11x | CN¥81.53 Million | CN¥768.71 Million | ▲ +61.5% |
| 2022 | 0.07x | CN¥57.13 Million | CN¥870.02 Million | ▼ -56.7% |
| 2021 | 0.15x | CN¥108.28 Million | CN¥714.65 Million | ▲ +29.3% |
| 2020 | 0.12x | CN¥224.54 Million | CN¥1.92 Billion | ▼ -6.4% |
| 2019 | 0.13x | CN¥231.30 Million | CN¥1.85 Billion | ▼ -21.5% |
| 2018 | 0.16x | CN¥225.89 Million | CN¥1.42 Billion | ▲ +164.3% |
| 2017 | 0.06x | CN¥61.39 Million | CN¥1.02 Billion | ▼ -61.1% |
| 2016 | 0.16x | CN¥125.66 Million | CN¥809.85 Million | ▲ +962.8% |
| 2015 | -0.02x | CN¥-25.41 Million | CN¥1.41 Billion | ▲ +55.3% |
| 2014 | -0.04x | CN¥-49.38 Million | CN¥1.23 Billion | ▼ -156.9% |
| 2013 | 0.07x | CN¥74.70 Million | CN¥1.06 Billion | ▲ +177.3% |
| 2012 | 0.03x | CN¥18.18 Million | CN¥713.21 Million | ▼ -9.5% |
| 2011 | 0.03x | CN¥11.85 Million | CN¥420.81 Million | ▼ -75.9% |
| 2010 | 0.12x | CN¥37.66 Million | CN¥322.42 Million | ▼ -59.8% |
| 2009 | 0.29x | CN¥37.35 Million | CN¥128.55 Million | ▲ +120.3% |
| 2008 | 0.13x | CN¥17.25 Million | CN¥130.77 Million | ▼ -35.0% |
| 2007 | 0.20x | CN¥21.68 Million | CN¥106.78 Million | ▲ +58.7% |
| 2006 | 0.13x | CN¥7.77 Million | CN¥60.72 Million | — |